Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine P815 model

International Journal of Cancer

Volumn 98, Issue 5, 2002, Pages 748-753

  Wu, Yuzhang ^a   Wan, Ying ^a   Bian, Jiang ^a   Zhao, Jianping ^a   Jia, ZhengCai ^a   Zhou, Liyun ^a   Zhou, Wei ^a   Tan, Yang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Anti tumor immunity; CTL; Immunotherapy; Phage display vaccine; Tumor specific antigens

Indexed keywords

CANCER VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; MASTOCYTOMA; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; TH1 CELL; TUMOR IMMUNITY;

ANIMALS; BASE SEQUENCE; CHROMIUM; DNA PRIMERS; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MICE; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PLASMIDS; SURVIVAL RATE; TH1 CELLS;

EID: 0037051714     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10260     Document Type: Article

References (38)

1. Human tumor antigens for cancer vaccine development
2. Immunological ignorance of silent antigens as an explanation of tumor evasion
3. Cutaneous malignant lymphomas
4. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes
5. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
6. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
7. Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma
8. Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses
9. Inducation of Hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamenous phage display vaccine
10. Design of specific immunogens using filamentous phage as the carrier
11. Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages
12. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice
13. The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection
14. Chimeric papillomavirus virus-like particles induce a murine self-antigen-specific protective and therapeutic antitumor immune response
15. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector
16. Indentification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
17. Serological identification of human tumor antigens
18. Immune surveillance against a solid tumor fails because of immunological ignorance
19. Hybrid cell vaccination for cancer immunotherapy
20. Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse
21. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
22. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
23. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
24. MHC-binding peptides as immunotherapeutics for cancer
25. Lipopeptide particles as the immunologically active component of CTL inducing vaccines
26. Development of non-live vectors and procedures (liposomes, pseudo-viral particles, toxin, beads, adjuvantsellipsis) as tools for cancer vaccines
27. Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8(+) cytotoxic T lymphocytes
28. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model
29. Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses
30. DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice
31. Fully mobilizing host defense: Building better vaccines
32. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent
33. Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: Induction of cytotoxic T-cell and humoral responses by a Gag: V3 fusion
34. Filamentous phage structure, infection and assembly
35. Factors limiting display of foreign peptides on the major coat protein of filamentous bacteriophage capsids and a potential role for leader peptidase
36. CD4+ T cell orchestrate both amplification and deletion of CD8+ T cells
37. Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: An effective vaccine design tested in murine cysticercosis
38. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal